Advanced search
Publication Cover
Climacteric Volume 19, 2016 - Issue 2
Submit an article Journal homepage
7,038
Views
586
CrossRef citations to date
0
Altmetric
Other

2016 IMS Recommendations on women’s midlife health and menopause hormone therapy

R. J. Baber
,
N. PanayCorrespondence[email protected]
&
A. Fenton the IMS Writing Group
Pages 109-150 | Published online: 12 Feb 2016

Citations (586)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (117)

Saira J Khan, Ekta Kapoor, Stephanie S Faubion & Juliana M Kling. (2023) Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives. International Journal of Women's Health 15, pages 273-287.
Read now
Ye Zhu, Xin Yang, Yanjie Wang & Xiaodong Zhu. (2023) Assessment of knowledge, understanding and awareness of Chinese women clinical staff towards menopause hormone therapy: a survey study. Journal of Obstetrics and Gynaecology 43:1.
Read now
Xiangyan Ruan, Zhongting Xu, Xin Xu, Yu Yang, Jiaojiao Cheng, Suiyu Luo, Min Min, Meng Li, Luping Zhang, Rui Ju, Fengyu Jin & Alfred Otto Mueck. (2023) A prospective study on the endometrium properties and the pregnancy rate of infertile women with thin endometrium receiving Fructus ligustri lucidi used in traditional Chinese medicine. Gynecological Endocrinology 39:1.
Read now
Hyun Joo Lee, Min Jung Park, Jeong-Doo Heo, Bo Sun Joo & Jong Kil Joo. (2023) Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model. Gynecological Endocrinology 39:1.
Read now
Barbara Campolina Silva & Marcio Alexandre Hipólito Rodrigues. (2023) Estrogen hormone therapy and postmenopausal osteoporosis: does it really take two to tango?. Women & Health 63:10, pages 770-773.
Read now
B. Sitini, P. Ntihinyurwa, D. Ntirushwa, L. Mafende, M. Small & S. Rulisa. (2023) Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda. Climacteric 26:6, pages 613-618.
Read now
M. Venetkoski, O. Ylikorkala, J. M. Joensuu, M. Gissler, T. S. Mikkola & H. Savolainen-Peltonen. (2023) Postmenopausal hormone therapy in prior pre-eclamptic women: a nationwide cohort study in Finland. Climacteric 26:6, pages 571-576.
Read now
S. A. Beshyah, L. Alwatban, A. Ekhzaimy, H. E. Mustafa, D. K. Abdelmannan, M. Merheb & M. Bashir. (2023) Management of menopause: a survey of physicians from the Middle East and Africa. Climacteric 26:5, pages 455-464.
Read now
Rita Pereira, Peter Krustrup, Carlo Castagna, Eduardo Coelho, Eva Wulff Helge, Niklas Rye Jørgensen, Carolina Vila-Chã, Sandra Martins, João Tiago Guimarães, José Magalhães & Susana Póvoas. (2023) Multicomponent recreational team handball training improves global health status in postmenopausal women at the long term – A randomised controlled trial. European Journal of Sport Science 23:8, pages 1789-1799.
Read now
R. Bonassi Machado, L. de Melo Pompei, E. A. P. Nahas, J. Nahas-Neto, L. da Costa-Paiva, S. Y. O. Del Debbio, M. Badalotti, M. C. O. Wender & A. M. Cruz. (2023) Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women. Climacteric 26:4, pages 401-407.
Read now
Serge Rozenberg, Nick Panay, Marco Gambacciani, Antonio Cano, Sarah Gray & Katrin Schaudig. (2023) Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective. Expert Review of Clinical Pharmacology 16:6, pages 507-517.
Read now
I. Lambrinoudaki & E. Armeni. (2023) Understanding of and clinical approach to cardiometabolic transition at the menopause. Climacteric 0:0, pages 1-7.
Read now
S. Cerdas Pérez. (2023) Menopause and diabetes. Climacteric 26:3, pages 216-221.
Read now
Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani & Barbara Gardella. (2023) Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?. Expert Opinion on Pharmacotherapy 24:1, pages 135-143.
Read now
L. Baquedano, P. Coronado, E. De la Viuda, S. Sánchez, B. Otero, I. Ramírez, P. Llaneza & N. Mendoza. (2023) Population-based survey on menopausal symptoms and treatment use. Climacteric 26:1, pages 47-54.
Read now
M. Sundell, A.-C. Spetz Holm, M. Fredrikson, M. Hammar, M. Hoffmann & J. Brynhildsen. (2022) Pulmonary embolism in menopausal hormone therapy: a population-based register study. Climacteric 25:6, pages 615-621.
Read now
T. Liu, S. Chen, G. I. Mielke, A. L. McCarthy & T. G. Bailey. (2022) Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis. Climacteric 25:6, pages 552-561.
Read now
Angelo Cagnacci & Ambrogio P. Londero. (2022) Hormone therapy in endometrial cancer survivors: time for a change. Gynecological Endocrinology 38:10, pages 795-796.
Read now
Mukun Yang, Shouqing Lin, Shurong Zheng, Aijun Sun, Meilu Bian, Shilan Li, Jianli Liu, Lina Hu, Ning Hui, Jing Zhong, Hongchun Hou, Tianfu Yue, Xiaoli Gao & Wenpei Bai. (2022) A multicenter, randomized, open, controlled trial to evaluate the efficacy of Honglilai Vaginal Cream and Premarin Vaginal Cream for Genitourinary Syndrome of Menopause in different subgroups of Chinese postmenopausal women. Gynecological Endocrinology 38:10, pages 861-867.
Read now
L. M. Pompei, R. Bonassi-Machado, M. L. Steiner, I. M. Pompei, N. R. de Melo, R. E. Nappi & C. E. Fernandes. (2022) Profile of Brazilian climacteric women: results from the Brazilian Menopause Study. Climacteric 25:5, pages 523-529.
Read now
X. Ruan & A. O. Mueck. (2022) Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view. Climacteric 25:5, pages 443-452.
Read now
C. C. Zouboulis, U. Blume-Peytavi, M. Kosmadaki, E. Roó, D. Vexiau-Robert, D. Kerob & S. R. Goldstein. (2022) Skin, hair and beyond: the impact of menopause. Climacteric 25:5, pages 434-442.
Read now
Gülşen Ak Sözer, Hatice Güdül Öz & Hatice Yangın. (2022) Relationship between menopausal symptoms and perceived stress during the COVID-19 pandemic. Journal of Women & Aging 34:5, pages 675-686.
Read now
Y. Deng, W. Wang, Q. Zheng, Y. Feng, Y. Zou, H. Dong, Z. Tan, X. Zeng, Y. Zhao, D. Peng, X. Yang & A. Sun. (2022) Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?. Climacteric 25:4, pages 413-420.
Read now
F. R. Pérez-López & S. R. Varikasuvu. (2022) Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex. Climacteric 25:4, pages 323-326.
Read now
L. M. Kaemmle, A. Stadler, H. Janka, M. von Wolff & P. Stute. (2022) The impact of micronized progesterone on cardiovascular events – a systematic review. Climacteric 25:4, pages 327-336.
Read now
Qi Yu & Lin Lin. (2022) The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals. Climacteric 25:3, pages 213-214.
Read now
K. Techatraisak, M. Rattanachaiyanont, P. Tanmahasamut, S. Indhavivadhana, T. Wongwananuruk & P. Jirakittidul. (2022) Impact of Global Consensus Statement on compliance with hormonal therapy for surgical menopause. Climacteric 25:3, pages 300-305.
Read now
M. Ren, X. Ruan, L. Gu, C. Pexman-Fieth, E. Kahler & Q. Yu. (2022) Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China. Climacteric 25:3, pages 286-292.
Read now
Gülçin Nacar & Sermin Timur Taşhan. (2022) Eating attitudes, depressive symptoms, physical activity levels and menopausal symptoms of postmenopausal women diagnosed with coronavirus disease 2019 (COVID-19): a case-control study. Women & Health 62:3, pages 223-233.
Read now
Rod Baber. (2022) Women’s health at midlife and beyond. Climacteric 25:2, pages 107-108.
Read now
Pasquale De Franciscis, Maurizio Guida, Antonio Schiattarella, Gaetano Riemma & Nicola Colacurci. (2022) Safety of non-hormonal medications for managing hot flashes. Expert Opinion on Drug Safety 21:2, pages 215-221.
Read now
Zhongting Xu, Xiangyan Ruan, Xin Xu, Yu Yang, Jiaojiao Cheng, Suiyu Luo, Min Min, Meng Li, Luping Zhang, Rui Ju, Fengyu Jin & Alfred Otto Mueck. (2022) Efficacy and safety of Zi Gui Nv Zhen® capsules used in TCM for fertility preservation in patients with diminished ovarian reserve. Gynecological Endocrinology 38:1, pages 73-77.
Read now
Maurizio Guida, Antonio Raffone, Antonio Travaglino, Daniele Neola, Sabrina Reppuccia, Maria Borgo, Clorinda Vitale, Andrea Limone, Pietro D’Alessandro, Giulia Massaro & Antonio Mollo. (2021) Cimicifuga racemosa isopropanolic extract for menopausal symptoms: an observational prospective case–control study. Gynecological Endocrinology 37:12, pages 1132-1137.
Read now
Fahimeh Ramezani Tehrani & Mina Amiri. (2021) The association between chronic diseases and the age at natural menopause: a systematic review. Women & Health 61:10, pages 917-936.
Read now
L. M. Pompei, M. C. O. Wender, J. Kulak$suffix/text()$suffix/text(), I. Pires, Y. Suvarna & R. E. Nappi. (2021) Impact of postmenopausal vaginal discomfort on sex and relationships in Brazil: the CLOSER survey. Climacteric 24:6, pages 593-599.
Read now
Sharon J. Parish, James A. Simon, Susan R. Davis, Annamaria Giraldi, Irwin Goldstein, Sue W. Goldstein, Noel N. Kim, Sheryl A. Kingsberg, Abraham Morgentaler, Rossella E. Nappi, Kwangsung Park, Cynthia A. Stuenkel, Abdulmaged M. Traish & Linda Vignozzi. (2021) International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Climacteric 24:6, pages 533-550.
Read now
T. J. de Villiers & S. R. Goldstein. (2021) Update on bone health: the International Menopause Society White Paper 2021. Climacteric 24:5, pages 498-504.
Read now
C. E. Upton, J. P. Daniels & M. C. Davies. (2021) Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy. Climacteric 24:5, pages 453-458.
Read now
I. Lambrinoudaki, S. A. Paschou, M. A. Lumsden, S. Faubion, E. Makrakis, S. Kalantaridou & N. Panay. (2021) Premature ovarian insufficiency: a toolkit for the primary care physician. Climacteric 24:5, pages 425-437.
Read now
Andrea R. Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Pharmacotherapeutic options for the treatment of menopausal symptoms. Expert Opinion on Pharmacotherapy 22:13, pages 1773-1791.
Read now
N. G. Jaff & P. M. Maki. (2021) Scientific insights into brain fog during the menopausal transition. Climacteric 24:4, pages 317-318.
Read now
C.-W. Park, S.-J. Lim, Y.-W. Moon, S.-H. Choi, M.-H. Shin, Y.-K. Min, B.-K. Yoon & Y.-S. Park. (2021) Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial. Climacteric 24:4, pages 408-414.
Read now
T. J. de Villiers & R. J. Baber. (2021) Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion?. Climacteric 24:4, pages 319-320.
Read now
N. Orprayoon, S. Santibenchakul, S. Hemrungrojn, P. Phutrakool, M. Kengsakul, U. Jaisamrarn & S. Chaikittisilpa. (2021) Effect of surgical menopause and frontal lobe cognitive function. Climacteric 24:4, pages 389-393.
Read now
S. Gasser, K. Heidemeyer, M. von Wolff & P. Stute. (2021) Impact of progesterone on skin and hair in menopause – a comprehensive review. Climacteric 24:3, pages 229-235.
Read now
Rui Ju, Xiangyan Ruan, Xin Xu, Yu Yang, Jiaojiao Cheng, Luping Zhang, Binhong Wang, Shuang Qin, Zhuli Dou & Alfred O. Mueck. (2021) Sexual dysfunction in Chinese women at different reproductive stages and the positive effect of hormone replacement therapy in the early postmenopause. The European Journal of Contraception & Reproductive Health Care 26:3, pages 246-254.
Read now
O. Y. Alshogran, F. Mz. Mahmoud & M. J. Alkhatatbeh. (2021) Knowledge and awareness toward menopause and hormone therapy among premenopausal women in Jordan. Climacteric 24:2, pages 171-178.
Read now
L. M. Pompei, M. C. O. Wender, N. R. de Melo, J. Kulak$suffix/text()$suffix/text(), D. Pardini, R. B. Machado, C. E. Fernandes, S. Palacios & R. E. Nappi. (2021) Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil. Climacteric 24:2, pages 157-163.
Read now
I. J. Rowe & R. J. Baber. (2021) The effects of phytoestrogens on postmenopausal health. Climacteric 24:1, pages 57-63.
Read now
R. D. Langer, H. N. Hodis, R. A. Lobo & M. A. Allison. (2021) Hormone replacement therapy – where are we now?. Climacteric 24:1, pages 3-10.
Read now
C. A. Stuenkel. (2021) Compounded bioidentical menopausal hormone therapy – a physician perspective. Climacteric 24:1, pages 11-18.
Read now
Y. Qin, X. Ruan, R. Ju, J. Pang, G. Zhao & X. Hu. (2021) Acupuncture for menopausal symptoms in Chinese women: a systematic review. Climacteric 24:1, pages 68-73.
Read now
Marcio Alexandre Hipolito Rodrigues & Anne Gompel. (2021) Micronized progesterone, progestins, and menopause hormone therapy. Women & Health 61:1, pages 3-14.
Read now
Marcio Hipolito Rodrigues & Marcia Carneiro. (2020) Peri and postmenopausal women in times of coronavirus pandemic. Women & Health 60:10, pages 1079-1082.
Read now
B. G. A. Stuckey, L. A. Mahoney, S. Dragovic & S. J. Brown. (2020) Celiac disease and bone health: is there a gap in the management of postmenopausal osteoporosis?. Climacteric 23:6, pages 559-565.
Read now
P. Proserpio, S. Marra, C. Campana, E. C. Agostoni, L. Palagini, L. Nobili & R. E. Nappi. (2020) Insomnia and menopause: a narrative review on mechanisms and treatments. Climacteric 23:6, pages 539-549.
Read now
D. Herbert, R. J. Bell, K. Young, H. Brown, J. Y. Coles & S. R. Davis. (2020) Australian women’s understanding of menopause and its consequences: a qualitative study. Climacteric 23:6, pages 622-628.
Read now
C. A. McCormick, A. Brennan & M. Hickey. (2020) Managing vasomotor symptoms effectively without hormones. Climacteric 23:6, pages 532-538.
Read now
M. Gambacciani, E. Albertin, M. G. Torelli, G. L. Bracco, A. C. Casagrande, L. Martella, G. Baiocchi, S. Alfieri, N. Russo & M. Cervigni. (2020) Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study. Climacteric 23:sup1, pages S24-S27.
Read now
T. C. Hillard. (2020) Lasers in the era of evidence-based medicine. Climacteric 23:sup1, pages S6-S10.
Read now
N. Panay, R. A. Anderson, R. E. Nappi, A. J. Vincent, S. Vujovic, L. Webber & W. Wolfman. (2020) Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric 23:5, pages 426-446.
Read now
Lingyan Zhang, Xiangyan Ruan, Yamei Cui, Muqing Gu & Alfred O Mueck. (2020) Menopausal Symptoms and Associated Social and Environmental Factors in Midlife Chinese Women. Clinical Interventions in Aging 15, pages 2195-2208.
Read now
S. Khandelwal. (2020) Obesity in midlife: lifestyle and dietary strategies. Climacteric 23:2, pages 140-147.
Read now
Yang Song, Wenxian Xu, Namratta Devi Chatooah, Jianfang Chen, Yizhou Huang, Peiqiong Chen, Yibing Lan, Chunming Li, Qian Ying, Linjuan Ma & Jianhong Zhou. (2020) Comparison of low dose versus ultra-low dose hormone therapy in menopausal symptoms and quality of life in perimenopause women. Gynecological Endocrinology 36:3, pages 252-256.
Read now
Svetlana Dragojević Dikić, Mladenko Vasiljević, Ana Jovanović, Srdjan Dikić, Aleksandar Jurišić, Ljubomir Srbinović & Svetlana Vujović. (2020) Premature ovarian insufficiency – novel hormonal approaches in optimizing fertility. Gynecological Endocrinology 36:2, pages 162-165.
Read now
F. Fruzzetti, G. Palla, M. Gambacciani & T. Simoncini. (2020) Tailored hormonal approach in women with premature ovarian insufficiency. Climacteric 23:1, pages 3-8.
Read now
Karen Oppermann, Veronica Colpani & Poli Mara Spritzer. (2019) Risk factors associated with coronary artery calcification in midlife women: a population-based study. Gynecological Endocrinology 35:10, pages 904-908.
Read now
David F. Archer, Brian A. Bernick & Sebastian Mirkin. (2019) A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause. Expert Review of Clinical Pharmacology 12:8, pages 729-739.
Read now
R. F. M. Vermeulen, C. M. Korse, G. G. Kenter, M. M. A. Brood-van Zanten & M. van Beurden. (2019) Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines. Climacteric 22:4, pages 352-360.
Read now
R. E. Nappi, L. Cucinella, E. Martini, M. Rossi, L. Tiranini, S. Martella, D. Bosoni & C. Cassani. (2019) Sexuality in premature ovarian insufficiency. Climacteric 22:3, pages 289-295.
Read now
M. Birkhaeuser, J. Bitzer, S. Braat & Y. Ramos. (2019) Esmirtazapine treatment of postmenopausal vasomotor symptoms: two randomized controlled trials. Climacteric 22:3, pages 312-322.
Read now
M. Gambacciani, A. Cagnacci & S. Lello. (2019) Hormone replacement therapy and prevention of chronic conditions. Climacteric 22:3, pages 303-306.
Read now
Tomas Fait, Manuela Sailer & Pedro-Antonio Regidor. (2019) Prospective observational study to evaluate the efficacy and safety of the pollen extract Sérélys® in the management of women with menopausal symptoms. Gynecological Endocrinology 35:4, pages 360-363.
Read now
C. A. Stuenkel. (2019) Do we have new preventive strategies for optimizing cardiovascular health in women?. Climacteric 22:2, pages 133-139.
Read now
A. Coquoz, C. Gruetter & P. Stute. (2019) Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review. Climacteric 22:2, pages 148-161.
Read now
Andrea R. Genazzani, Ulysse Gaspard & Jean-Michel Foidart. (2019) Oral investigational drugs currently in phase I or phase II for the amelioration of menopausal symptoms. Expert Opinion on Investigational Drugs 28:3, pages 235-247.
Read now
M. Shapiro. (2019) What should guide our patient management of vulvovaginal atrophy?. Climacteric 22:1, pages 38-43.
Read now
S. Shah, H. H. Nguyen & A. J. Vincent. (2018) Care of the adult woman with Turner syndrome. Climacteric 21:5, pages 428-436.
Read now
Y. Huang, N. D. Chatooah, T. Qi, G. Wang, L. Ma, Q. Ying, Y. Lan, Y. Song, C. Li, K. Chu, P. Chen, W. Xu, H. Wan, Y. Cai & J. Zhou. (2018) Health-related quality of life and its associated factors in Chinese middle-aged women. Climacteric 21:5, pages 483-490.
Read now
D. A. Davey. (2018) Menopausal hormone therapy: a better and safer future. Climacteric 21:5, pages 454-461.
Read now
P. Piette. (2018) The history of natural progesterone, the never-ending story. Climacteric 21:4, pages 308-314.
Read now
P.-Y. Scarabin. (2018) Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis. Climacteric 21:4, pages 341-345.
Read now
D. A. Tan & M. J. G. Almaria. (2018) Postmenopausal endometriosis: drawing a clearer clinical picture. Climacteric 21:3, pages 249-255.
Read now
L. Gao, H. Zuo, T. Zheng, W. Xue, Y. Wang, Y. Deng & A. Sun. (2018) Influence of hormone therapy or C. foetida extract on breast tenderness in postmenopausal women. Climacteric 21:3, pages 292-297.
Read now
Lihong Gao, Xiaojie Wu, Xia Liu, Qinglan Pu, Meiguang Zhang, Yingru Cai, Lizhong Wang, Wei Zhao & Jiming Chen. (2018) Awareness of hormone replacement therapy in medical care personnel in Jiaxing, China: a questionnaire survey. Gynecological Endocrinology 34:4, pages 332-335.
Read now
M. Gambacciani, M. Levancini, E. Russo, L. Vacca, T. Simoncini & M. Cervigni. (2018) Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric 21:2, pages 148-152.
Read now
P. Stute, L. Wildt & J. Neulen. (2018) The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 21:2, pages 111-122.
Read now
A. O. Mueck, X. Ruan, V. Prasauskas, P. Grob & O. Ortmann. (2018) Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review. Climacteric 21:2, pages 140-147.
Read now
K. Chu, Y. Song, N. D. Chatooah, Q. Weng, Q. Ying, L. Ma, F. Qu & J. Zhou. (2018) The use and discontinuation of hormone replacement therapy in women in South China. Climacteric 21:1, pages 47-52.
Read now
S. Palacios, M. Lilue, A. Mejia & C. Menendez. (2017) Omega-3 versus isoflavones in the control of vasomotor symptoms in postmenopausal women. Gynecological Endocrinology 33:12, pages 951-957.
Read now
Rod Baber. (2017) Teaching the teachers. Climacteric 20:6, pages 503-504.
Read now
D. Pu, R. Tan, Q. Yu & J. Wu. (2017) Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric 20:6, pages 583-591.
Read now
Timothy C. Hillard. (2017) Turning the spotlight on lasers. Climacteric 20:5, pages 397-399.
Read now
R. D. Langer, J. A. Simon, A. Pines, R. A. Lobo, H. N. Hodis, J. H. Pickar, D. F. Archer, P. M. Sarrel & W. H. Utian. (2017) Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. Climacteric 20:5, pages 402-413.
Read now
Keli L. Beck, Michelle C. Anderson & Julienne K. Kirk. (2017) Transdermal estrogens in the changing landscape of hormone replacement therapy. Postgraduate Medicine 129:6, pages 632-636.
Read now
C. Rueda, A. M. Osorio, A. C. Avellaneda, C. E. Pinzón & O. I. Restrepo. (2017) The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review. Climacteric 20:4, pages 321-330.
Read now
Y. Chua, K. K. Limpaphayom, B. Cheng, C. M. Ho, K. Sumapradja, C. Altomare & K. Huang. (2017) Genitourinary syndrome of menopause in five Asian countries: results from the Pan-Asian REVIVE survey. Climacteric 20:4, pages 367-373.
Read now
N. Biglia, A. Cagnacci, M. Gambacciani, S. Lello, S. Maffei & R. E. Nappi. (2017) Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?. Climacteric 20:4, pages 306-312.
Read now
I. Ilovayskaya, V. Zektser & L. Lazebnik. (2017) Similarity of female central (hypogonadotropic) hypogonadism and postmenopause. Climacteric 20:4, pages 356-361.
Read now
D. W. Sturdee, M. S. Hunter, P. M. Maki, P. Gupta, J. Sassarini, J. C. Stevenson & M. A. Lumsden. (2017) The menopausal hot flush: a review. Climacteric 20:4, pages 296-305.
Read now
L. Yeganeh, J. Boyle, H. Teede & A. Vincent. (2017) Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric 20:4, pages 348-355.
Read now
A. Gentry-Maharaj, C. Karpinskyj, C. Glazer, M. Burnell, K. Bailey, S. Apostolidou, A. Ryan, A. Lanceley, L. Fraser, I. Jacobs, M. S. Hunter & U. Menon. (2017) Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening. Climacteric 20:3, pages 240-247.
Read now
M. L’Hermite. (2017) Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use. Climacteric 20:3, pages 205-211.
Read now
H. P. G. Schneider & M. Birkhäuser. (2017) Quality of life in climacteric women. Climacteric 20:3, pages 187-194.
Read now
R. D. Langer. (2017) The evidence base for HRT: what can we believe?. Climacteric 20:2, pages 91-96.
Read now
R. J. Baber & J. Wright. (2017) A brief history of the International Menopause Society. Climacteric 20:2, pages 85-90.
Read now
C. A. Stuenkel. (2017) Menopause, hormone therapy and diabetes. Climacteric 20:1, pages 11-21.
Read now
Rod Baber. (2016) Are we there yet?. Climacteric 19:6, pages 520-521.
Read now
Chiara Bondi, Simone Ferrero, Carolina Scala, Emanuela Tafi, Annalisa Racca, Pier Luigi Venturini & Umberto Leone Roberti Maggiore. (2016) Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1233-1246.
Read now
Manuel Cortés-Bonilla, Rosalba Alonso-Campero, Roberto Bernardo-Escudero, María T. Francisco-Doce, Juan Chavarín-González, Ricardo Pérez-Cuevas & Peter Chedraui. (2016) Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone. Gynecological Endocrinology 32:10, pages 831-834.
Read now
Nick Panay & Anna Fenton. (2016) Climacteric: past, present and future!. Climacteric 19:5, pages 413-414.
Read now
Anna Fenton & Nick Panay. (2016) Global consensus statement on menopausal hormone therapy – an update. Climacteric 19:4, pages 311-312.
Read now
T. J. de Villiers, J. E. Hall, J. V. Pinkerton, S. Cerdas Pérez, M. Rees, C. Yang & D. D. Pierroz. (2016) Revised Global Consensus Statement on Menopausal Hormone Therapy. Climacteric 19:4, pages 313-315.
Read now
Nick Panay & Anna Fenton. (2016) Menopause in the 21st century: the need for research and development. Climacteric 19:3, pages 213-214.
Read now
S. Bontempo, L. Yeganeh, R. Giri & A. J. Vincent. Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis. Climacteric 0:0, pages 1-11.
Read now
Tamlyn Anne Rautenberg, Martin Downes, Tommaso Simoncini, Yu Qi, Mulan Ren, Yaping Wang, Custodio Marcelo Graziano & Kyoo Kim. Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China. Journal of Medical Economics 0:0, pages 1-36.
Read now

Articles from other publishers (469)

Lora Todorova, Rogerio Bonassi, Francisco Javier Guerrero Carreño, Angelica L. Hirschberg, Nese Yuksel, Carol Rea, Ludmila Scrine & Janet S. Kim. (2023) Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey. Menopause 30:12, pages 1179-1189.
Crossref
Xuechun Ding, Shenmin Lv, Zhipeng Guo, Xiaowei Gong, Caiqin Wang, Xiaoyan Zhang & Kai Meng. (2023) Potential Therapeutic Options for Premature Ovarian Insufficiency: Experimental and Clinical Evidence. Reproductive Sciences 30:12, pages 3428-3442.
Crossref
Sophie Behrman & Clair Crockett. (2023) Severe mental illness and the perimenopause. BJPsych Bulletin, pages 1-7.
Crossref
E. V. Shlyakhto, G. T. Sukhikh, V. N. Serov, I. I. Dedov, G. P. Arutyunov, I. A. Suchkov, Ya. A. Orlova, E. N. Andreeva, S. V. Yureneva, I. S. Yavelov, M. I. Yarmolinskaya, S. V. Villevalde, O. R. Grigoryan, E. N. Dudinskaya, E. A. Ilyukhin, N. A. Koziolova, I. V. Sergienko, A. A. Smetnik & N. I. Tapilskaya. (2023) Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia. Problems of Endocrinology 69:5, pages 115-136.
Crossref
E. V. Shlyakhto, G. T. Sukhikh, V. N. Serov, I. I. Dedov, G. P. Arutyunov, I. A. Suchkov, Ya. A. Orlova, E. N. Andreeva, S. V. Yureneva, I. S. Yavelov, M. I. Yarmolinskaya, S. V. Villevalde, O. R. Grigoryan, E. N. Dudinskaya, E. A. Ilyukhin, N. A. Koziolova, I. V. Sergienko, A. A. Smetnik & N. I. Tapilskaya. (2023) Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP. Kardiologiia 63:10, pages 9-28.
Crossref
Wan-Yu Zhang, Han-Bi Wang & Cheng-Yan Deng. (2023) Intermittent spontaneous ovulation in patients with premature ovarian failure: Three case reports and review of literature. World Journal of Clinical Cases 11:31, pages 7647-7655.
Crossref
Lauren McVicker, Alexander M. Labeit, Carol A. C. Coupland, Blánaid Hicks, Carmel Hughes, Úna McMenamin, Stuart A. McIntosh, Peter Murchie & Chris R. Cardwell. (2023) Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer. JAMA Oncology.
Crossref
Denise Black. (2023) Menopause Hormone Therapy: 2023 Update. Canadian Primary Care Today, pages 17-21.
Crossref
Vaishvi Patel, Sue Ross & Beate C. Sydora. (2023) Assessing young adults' menopause knowledge to increase understanding of symptoms and help improve quality of life for women going through menopause; a student survey. BMC Women's Health 23:1.
Crossref
Jin-Sung Yuk, Jin San Lee & Joong Hyun Park. (2023) Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study. Frontiers in Aging Neuroscience 15.
Crossref
Jie Lu, Kangfen Li, Xinlie Zheng, Ran Liu, Min Chen, Jingyun Xian, Suhua Tu & Lingling Xie. (2023) Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study. BMC Women's Health 23:1.
Crossref
Susan R. Davis, JoAnn Pinkerton, Nanette Santoro & Tommaso Simoncini. (2023) Menopause—Biology, consequences, supportive care, and therapeutic options. Cell 186:19, pages 4038-4058.
Crossref
Mohammed M. Hassanein, Hasniza Zaman Huri, Abduelmula R. Abduelkarem & Kauser Baig. (2023) Therapeutic Effects of Vitamin D on Vaginal, Sexual, and Urological Functions in Postmenopausal Women. Nutrients 15:17, pages 3804.
Crossref
Gabriel Fiol, Iñaki Lete, Laura Nieto, Ana Santaballa, María Jesús Pla, Laura Baquedano, Joaquín Calaf, Pluvio Coronado, Esther de la Viuda, Plácido Llaneza, Borja Otero, Sonia Sánchez-Méndez, Isabel Ramírez & Nicolas Mendoza. (2023) Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review. Journal of Clinical Medicine 12:16, pages 5263.
Crossref
Erin R Duralde, Talia H Sobel & JoAnn E Manson. (2023) Management of perimenopausal and menopausal symptoms. BMJ, pages e072612.
Crossref
Antonio J. Mateo-Orobia, Eduardo del Prado Sanz, Alejandro Blasco-Martínez, Luis E. Pablo-Júlvez, Sarah Farrant & Frédéric Chiambaretta. (2023) Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42–54 versus ≥ 55 years. Contact Lens and Anterior Eye 46:4, pages 101845.
Crossref
Alexander L.Z. Abouharb, Sachit Mehta, Hasithe Rathnayake & Hemant Pandit. (2023) Withholding of Hormone Replacement Therapy Prior to Total Joint Arthroplasty Surgery to Reduce the Risk of Postoperative Thromboembolic Events: Is It Justified?—A Systematic Review of Clinical Practice Guidelines. The Journal of Arthroplasty.
Crossref
Jiaman Wu, Liya Tan, Yan Ning, Weiqu Yuan, Zuowei Lee, Fei Ma, Erfeng Wang & Yuanyuan Zhuo. (2023) Characteristics of retinal image associated with premature ovarian insufficiency: a case- control study. Journal of Ovarian Research 16:1.
Crossref
Martin C. Michel, Linda Cardozo, Christopher J. Chermansky, Francisco Cruz, Yasuhiko Igawa, Kyu-Sung Lee, Arun Sahai, Alan J. Wein & Karl-Erik Andersson. (2023) Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders. Pharmacological Reviews 75:4, pages 554-674.
Crossref
Ying-Ju Ou, Jia-In Lee, Shu-Pin Huang, Szu-Chia Chen, Jiun-Hung Geng & Chia-Hung Su. (2023) Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome. Journal of Clinical Medicine 12:13, pages 4435.
Crossref
Nadia Meziou, Clare Scholfield, Caroline A. Taylor & Heather L. Armstrong. (2023) Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update. Menopause 30:6, pages 659-671.
Crossref
Rui Ju, Xiangyan Ruan, Yu Yang, Xin Xu, Jiaojiao Cheng, Yongtao Bai, Yanhong Shi, Xingzi Yang, Ruiling Li & Alfred O. Mueck. (2023) A multicentre cross-sectional clinical study on female sexual dysfunction in postmenopausal Chinese women. Maturitas 172, pages 15-22.
Crossref
O. L. Lovkina, N. G. Masibroda, O. A. Muntyan, V. V. Klivak & A. V. Vozniuk. (2023) The impact of today’s chronic stress on a woman’s menstrual function. Reports of Vinnytsia National Medical University 27:2, pages 331-335.
Crossref
Marta Caretto, Elisa Casula, Ilaria Catrambone, Andrea Giannini & Tommaso Simoncini. (2023) Ten-point guide on the management of healthy women carrying BRCA1/2 mutations. Maturitas 171, pages 21-23.
Crossref
Tobie J. de Villiers. (2023) Bone health and menopause: Osteoporosis prevention and treatment. Best Practice & Research Clinical Endocrinology & Metabolism, pages 101782.
Crossref
O. V. Yakushevskaya. (2023) The effects of hormone replacement therapy: а window of opportunity for the cardiovascular system. Meditsinskiy sovet = Medical Council:5, pages 148-154.
Crossref
Lucia Merlino, Giulia D’Ovidio, Viviana Matys, Maria Grazia Piccioni, Maria Grazia Porpora, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale & Carlo Della Rocca. (2023) Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals 16:4, pages 550.
Crossref
Xiaoyan He, Xiangyin Lv, Binbin Zhang, Xiaoxuan Ying, Chiyu Hu, Xiaoying Zhou & Jianwen Hu. (2023) Adenoma Detection Rate in Average-Risk Population: An Observational Consecutive Retrospective Study. Cancer Control 30.
Crossref
Jing Zhu, Ling Zhang, Mengxia Ji, Bihui Jin & Jing Shu. (2023) Elevated adipose differentiation‐related protein level in ovariectomized mice correlates with tissue‐specific regulation of estrogen. Journal of Obstetrics and Gynaecology Research 49:4, pages 1173-1179.
Crossref
Nandi Shah & Danit Ariel. (2023) The role of menopausal hormone therapy in the prevention and treatment of low bone density in perimenopausal and postmenopausal women. Current Opinion in Obstetrics & Gynecology 35:2, pages 141-149.
Crossref
Young Ju Jeong, Hye Ryeon ChoiKyung-Soon KimIm Hee ShinSung Hwan Park. (2023) Impact of Acupuncture on Hot Flashes in Breast Cancer Patients Receiving Adjuvant Antiestrogen Therapy with Tamoxifen: A Randomized Controlled Trial. Journal of Integrative and Complementary Medicine 29:4, pages 241-252.
Crossref
Nicole Petersen, Adriene M. Beltz, Kathleen V. Casto, Caitlin M. Taylor, Emily G. Jacobs, Inger Sundström-Poromaa & Belinda Pletzer. (2023) Towards a more comprehensive neuroscience of hormonal contraceptives. Nature Neuroscience 26:4, pages 529-531.
Crossref
Herman Depypere, Andrea Vergallo, Pablo Lemercier, Simone Lista, Andrea Benedet, Nicholas Ashton, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen & Harald Hampel. (2022) Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease. Alzheimer's & Dementia 19:4, pages 1320-1330.
Crossref
Yangmei Li, Haiyang He, Jiaxi Wang, Yifan Chen, Chunyuan Wang, Xinyue Li, Anqi Dai, Yue Liu, Xin Xi, Juan Huang, Mi Zou, Yao Fan, Mingfang Zhou, Ping Yi, Lili Yu & Xun Lei. (2023) Effect of multidisciplinary health education based on lifestyle medicine on menopausal syndrome and lifestyle behaviors of menopausal women: A clinical controlled study. Frontiers in Public Health 11.
Crossref
Zhanna Belaya, Liudmila Rozhinskaya, Ivan Dedov, Oksana Drapkina, Valentin Fadeev, Olga Golounina, Olga Lesnyak, Elizaveta Mamedova, Galina Melnichenko, Alexey Petraikin, Svetlana Rodionova, Irina Skripnikova, Olga Tkacheva, Natalia Toroptsova, Svetlana Yureneva & John A. Kanis. (2023) A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis. Osteoporosis International 34:3, pages 429-447.
Crossref
Andrea García-Llorca & Georgios Kararigas. (2023) Sex-Related Effects of Gut Microbiota in Metabolic Syndrome-Related Diabetic Retinopathy. Microorganisms 11:2, pages 447.
Crossref
Serena Bertozzi, Ambrogio Londero, Anjeza Xholli, Guglielmo Azioni, Roberta Di Vora, Michele Paudice, Ines Bucimazza, Carla Cedolini & Angelo Cagnacci. (2023) Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review. Journal of Clinical Medicine 12:4, pages 1422.
Crossref
Ekta Kapoor. (2023) Premature ovarian insufficiency. Current Opinion in Endocrine and Metabolic Research 28, pages 100435.
Crossref
Tae-Hoon Kim, ByoungRyun Kim, Youe Ree Kim, Chang-Won Jeong & Young Hwan Lee. (2023) Gray matter differences associated with menopausal hormone therapy in menopausal women: a DARTEL-based VBM study. Scientific Reports 13:1.
Crossref
Wenxian Xu, Yizhou Huang, Linjuan Ma, Peiqiong Chen, Saisai Li, Ketan Chu, Yibing Lan, Chunming Li, Yang Song, Qian Ying & Jianhong Zhou. (2023) Clinical observation of menopause hormone therapy in postmenopausal women with euthyroid and mild subclinical hypothyroidism. BMC Endocrine Disorders 23:1.
Crossref
Cynthia A. Stuenkel & Anne Gompel. (2023) Primary Ovarian Insufficiency. New England Journal of Medicine 388:2, pages 154-163.
Crossref
M. V. Koval & A. A. Udachina. (2023) Role of vitamin D in formation of climacteric syndrome. Perm Medical Journal 39:6, pages 5-10.
Crossref
Laura Pivazyan, Julietta AvetisyanMaria LoshkarevaAmina Abdurakhmanova. (2023) Skin Rejuvenation in Women using Menopausal Hormone Therapy: A Systematic Review and Meta-Analysis. Journal of Menopausal Medicine 29.
Crossref
莹莹 范. (2023) Current Status of MHT Treatment for Menopausal Syndrome. Advances in Clinical Medicine 13:04, pages 5396-5400.
Crossref
Jing Zhu, Yier Zhou, Bihui Jin & Jing Shu. (2023) Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective. Therapeutic Advances in Endocrinology and Metabolism 14.
Crossref
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin e1 e39 .
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin 19 58 .
Jin Kyung Kim. 2023. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine 681 697 .
Jinjin Zhang, Minli Zhang, Aiyue Luo, Shuhong Yang, Lu Shen, Man Wang, Tong Wu & Zhiyong Lu. 2023. Ovarian Aging. Ovarian Aging 199 238 .
Ting Ding, Jingjing Jiang, Yan Zhang, Li Fang, Jun Dai, Yueyue Gao, Xiaofang Du, Jingyi Wen & Yan Li. 2023. Ovarian Aging. Ovarian Aging 173 198 .
Svetlana Kalinchenko, Igor Tyuzikov, George Mskhalaya & Yulia Tishova. 2023. Testosterone. Testosterone 281 301 .
Svetlana Vujovic, Miomira Ivovic, Milina Tancic Gajic, Ljiljana Marina & Svetlana Dragojevic-Dikic. 2023. Amenorrhea. Amenorrhea 157 178 .
Burcu ÖSKAN FIRAT & Ergül ASLAN. (2022) Menopoz Semptomlarına Özgü Güncel Kanıt Temelli UygulamalarCurrent Evidence-Based Practices for Menopausal Symptoms. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 11:4, pages 1609-1618.
Crossref
Scott Burns, Ashley Selman, Ujala Sehar, Priyanka Rawat, Arubala P. Reddy & P. Hemachandra Reddy. (2022) Therapeutics of Alzheimer’s Disease: Recent Developments. Antioxidants 11:12, pages 2402.
Crossref
Dana Alsugeir, Li Wei, Matthew Adesuyan, Sarah Cook, Nicholas Panay & Ruth Brauer. (2022) Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study. BJGP Open 6:4, pages BJGPO.2022.0126.
Crossref
Stefano LELLO, Anna CAPOZZI, Anjeza XHOLLI & Angelo CAGNACCI. (2022) The benefits of purified cytoplasm of pollen in reducing menopausal symptoms in peri- and post-menopause: an Italian multicenter prospective observational study. Minerva Obstetrics and Gynecology 74:6.
Crossref
Haitham Hamoda, Annice Mukherjee, Edward Morris, Stephanie E Baldeweg, Channa N Jayasena, Paula Briggs & Sara Moger. (2022) Authors reply: ‘Response to the British Menopause society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology position statement – Best practice recommendations for the care of women experiencing the menopause’. Post Reproductive Health 28:4, pages 254-258.
Crossref
Florence A. Trémollieres, Gabriel André, Brigitte Letombe, Luc Barthélemy, Amélie Pichard, Bertrand Gelas & Patrice Lopès. (2022) Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management. Maturitas 166, pages 58-64.
Crossref
Tobias De Villiers. (2022) The management of vasomotor symptoms of menopause (VMS) with menopausal hormone therapy (MHT). Current Opinion in Endocrine and Metabolic Research 27, pages 100420.
Crossref
Rossella E Nappi. (2022) The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news. The Lancet Diabetes & Endocrinology 10:12, pages 832-834.
Crossref
Juliana Mendes Abreu, Amanda B. B. Nogueira, Mariana M. Villela, Denise M. Módolo, Thaís C. Panaro, Sérgio Setubal, Luiz Guillermo C. Velarde, Giovanna A. B. Lima, Rubens A. da Cruz Filho & Debora V. Soares. (2022) Low bone mass and vitamin D in Brazilian people living with HIV under antiretroviral therapy. Archives of Osteoporosis 17:1.
Crossref
E. N. Andreeva & E. V. Sheremetyeva. (2022) The role of estriol in the treatment of atrophy of the mucous membrane of the lower genitourinary tract in postmenopausal women. Problems of Endocrinology 68:6, pages 157-163.
Crossref
Ambrogio P. Londero, Anjeza Xholli, Serena Bertozzi, Maria Orsaria, Michele Paudice, Laura Mariuzzi & Angelo Cagnacci. (2022) Quantification of Women Who Could Benefit from Hormone Therapy after Endometrial Cancer Treatment: An Analysis of SEER Data. Current Oncology 29:12, pages 9215-9223.
Crossref
Muhamed Lahtif Nor Muhamad, Sophia Ogechi Ekeuku, Sok-Kuan Wong & Kok-Yong Chin. (2022) A Scoping Review of the Skeletal Effects of Naringenin. Nutrients 14:22, pages 4851.
Crossref
Tejal Lathia, Chitra Selvan, Shraddha Namjoshi, Shweta Chawak, Lauren Kelada & Mahati Chittem. (2022) Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion. Menopause 29:11, pages 1323-1328.
Crossref
Laura E. Korthauer, Joseph S. Goveas, Stephen R. Rapp, Mark A. Espeland, Sally A. Shumaker, Katelyn R. Garcia, Rebecca C. Rossom, Lorena Garcia, Hilary A. Tindle, Elena Salmoirago‐Blotcher, Sylvia Wassertheil‐Smoller, Oleg Zaslavsky, Barbara Cochrane, Kaycee M. Sink, Kamal Masaki & Ira Driscoll. (2022) The relationship between depressive symptoms and subtypes of mild cognitive impairment in post‐menopausal women: Results from the Women's Health Initiative Memory Study. International Journal of Geriatric Psychiatry 37:11.
Crossref
Yu Deng, He Huang, Jiangcheng Shi & Hongyan Jin. (2022) Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis. International Journal of Molecular Sciences 23:19, pages 11892.
Crossref
Luján Irastorza Jesús Estuardo, Di Silvio-López Mauricio, Durand-Montaño Carlos, Hernández-Ramos Roberto, Ávila-Pérez Felipe de Jesús, Myslabodski Julio, Pariente-Fernández Maruxa, Paredes-Núñez María Angélica, Pacheco-Pineda Josué Giovani & Vargas-Hernández Víctor Manuel. (2022) Mesenchymal stem cells as an adjuvant for the treatment of poi, and as a support in expectant management of placental hematomas and premature rupture of membranes: case report. Obstetrics & Gynecology International Journal 13:5, pages 305-309.
Crossref
Michael T. Yin, Donald R. Hoover, Qiuhu Shi, Phyllis C. Tien, Mardge H. Cohen, Seble Kassaye, Deborah Gustafson, Adaora Adimora, M. Neale Weitzmann, Hector Bolivar, Amy Warriner, Sara H. Bares & Anjali Sharma. (2022) Hormone therapy and fractures in postmenopausal women. AIDS 36:12, pages 1683-1688.
Crossref
Jennifer-Christin Kuchernig. (2022) Cimicifuga racemosa: Einblicke in Wirkmechanismus und extraktspezifische Wirksamkeit und Sicherheit. Zeitschrift für Phytotherapie 42:05, pages 199-203.
Crossref
Marco Gambacciani & Angelo Cagnacci. (2022) HRT in a new light: Thanks UK. Maturitas 164, pages 98-99.
Crossref
Amit Kiran, Neil M. Schultz, Emad Siddiqui, Lora Todorova, Bas Van der Poel, Matthias Stoelzel & Lynne Robinson. (2022) Epidemiology and treatment patterns of UK women diagnosed with vasomotor symptoms: Findings from the Clinical Practice Research Datalink GOLD database. Maturitas 164, pages 1-8.
Crossref
Van T. Hoang, Hoang-Phuong Nguyen, Viet Nhan Nguyen, Duc M. Hoang, Tan-Sinh Thi Nguyen & Liem Nguyen Thanh. (2022) “Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial”. Frontiers in Cell and Developmental Biology 10.
Crossref
Holly Brettle, Vivian Tran, Grant R. Drummond, Ashley E. Franks, Steve Petrovski, Antony Vinh & Maria Jelinic. (2022) Sex hormones, intestinal inflammation, and the gut microbiome: Major influencers of the sexual dimorphisms in obesity. Frontiers in Immunology 13.
Crossref
Haitham Hamoda, Annice Mukherjee, Edward Morris, Stephanie E Baldeweg, Channa N Jayasena, Paula Briggs & Sara Moger. (2022) Optimising the menopause transition: Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause. Post Reproductive Health 28:3, pages 121-122.
Crossref
Irene Lambrinoudaki, Eleni Armeni, Dimitrios Goulis, Silvia Bretz, Iuliana Ceausu, Fatih Durmusoglu, Risto Erkkola, Ivan Fistonic, Marco Gambacciani, Marije Geukes, Haitham Hamoda, Caiomhe Hartley, Angelica Lindén Hirschberg, Blazej Meczekalski, Nicolas Mendoza, Alfred Mueck, Antonina Smetnik, Petra Stute, Mick van Trotsenburg & Margaret Rees. (2022) Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society. Maturitas 163, pages 1-14.
Crossref
Zhiwei Xu, Hsin-Fang Chung, Annette J Dobson, Louise F Wilson, Martha Hickey & Gita D Mishra. (2022) Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants. Human Reproduction 37:9, pages 2175-2185.
Crossref
O.О. Yefimenko. (2022) Menopauseal hormonal therapy and the risk of breast cancer in the light of new data. REPRODUCTIVE ENDOCRINOLOGY:66, pages 77-80.
Crossref
D.H. Konkov, О.А. Taran, V.O. Rud & V.V. Klyvak. (2022) The features of optimal nonhormonal therapy of vegetative disorders among women with postmenopause. REPRODUCTIVE ENDOCRINOLOGY:65, pages 90-96.
Crossref
. (2022) Resolution of the III International menopause expert forum. REPRODUCTIVE ENDOCRINOLOGY:65, pages 80-88.
Crossref
Ganna Zaychenko, Olena Stryga, Oksana Sinitsyna, Anna Doroshenko, Oksana Sulaieva, Tetyana Falalyeyeva & Nazarii Kobyliak. (2022) Resveratrol Effects on the Reproductive System in Ovariectomized Rats: Deciphering Possible Mechanisms. Molecules 27:15, pages 4916.
Crossref
Marina Averyanova, Polina Vishnyakova, Svetlana Yureneva, Oksana Yakushevskaya, Timur Fatkhudinov, Andrey Elchaninov & Gennady Sukhikh. (2022) Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic. Frontiers in Immunology 13.
Crossref
Susan R. Davis & Rodney J. Baber. (2022) Treating menopause — MHT and beyond. Nature Reviews Endocrinology 18:8, pages 490-502.
Crossref

Displaying 200 of 586 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.